These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3796630)

  • 1. Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions.
    Chang NS; Boackle RJ
    Mol Immunol; 1986 Aug; 23(8):887-93. PubMed ID: 3796630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual complement-mediated hemolytic kinetics at low ionic strength.
    Chang NS; Boackle RJ
    Mol Immunol; 1985 Oct; 22(10):1217-24. PubMed ID: 4079941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
    Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
    J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells.
    Damon DH; D'Amore PA; Wagner JA
    J Cell Physiol; 1988 May; 135(2):293-300. PubMed ID: 2967302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
    Caughman GB; Boackle RJ; Vesely J
    Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous glycosaminoglycans stimulate hyaluronic acid synthesis by cultured human trabecular-meshwork cells.
    Binninger EA; Schachtschabel DO; Rohen JW
    Exp Eye Res; 1987 Jul; 45(1):169-77. PubMed ID: 2958306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H.
    Meri S; Pangburn MK
    Biochem Biophys Res Commun; 1994 Jan; 198(1):52-9. PubMed ID: 8292049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
    J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of optimal reaction conditions for an assay of the human alternative complement pathway.
    Joiner KA; Hawiger A; Gelfand JA
    Am J Clin Pathol; 1983 Jan; 79(1):65-72. PubMed ID: 6849295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
    Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
    J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycan stimulation of calcium release from mouse calvariae. Specificity for hyaluronic acid and dermatan sulfate.
    Cochran DL
    Calcif Tissue Int; 1987 Aug; 41(2):79-85. PubMed ID: 3115549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans enhance human leukemic cell growth in vitro.
    Maurer AM; Han ZC; Dhermy D; Brière J
    Leuk Res; 1994 Nov; 18(11):837-42. PubMed ID: 7967710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
    Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
    Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro glycosaminoglycans from human dental pulp.
    Mangkornkarn C; Steiner JC
    J Endod; 1992 Jul; 18(7):327-31. PubMed ID: 1402594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans.
    Hamazaki H
    Biochem Biophys Res Commun; 1988 Jan; 150(1):212-8. PubMed ID: 3276308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.